±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 404  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

wxh7420238

Òø³æ (СÓÐÃûÆø)

[ÇóÖú] Ìæ¿¼À­Äþ¡¢Íò¹ÅÃ¹ËØÎÄÕ·­Òë

1¡¢Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study
2¡¢Objectives: Higher vancomycin MIC values (¡Ý1.5 mg/L via Etest) may be associated with vancomycin treatment failure among patients with serious methicillin-resistant Staphylococcus aureus (MRSA) infections.
3¡¢Teicoplanin Etestw MICs and treatment outcomes for MRSA bacteraemia were reviewed to identify the breakpoint of teicoplanin MICs influencing treatment outcomes.
4¡¢A lower teicoplanin MIC was associated with a favourable outcome [37 (66.1%) versus 13 (28.9%); P,0.001] and a lower rate of bloodstream infection-related mortality [15 (26.8%) versus 22 (48.9%); P¼0.022].
5¡¢ A higher teicoplanin MIC value (.1.5 mg/L) may predict an unfavourable outcome and highermortality rate among teicoplanin-treated MRSA bacteraemic patients.

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Isaya_12

Òø³æ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
°®ÓëÓêÏÂ: ½ð±Ò+1 2013-05-28 21:53:44
wxh7420238: ½ð±Ò+25, ·­ÒëEPI+1, ¡ï¡ï¡ïºÜÓаïÖú 2013-05-31 15:58:39
1.Ìæ¿¼À­ÄþµÄ×îСÒÖ¾úŨ¶È¶Ô¸ÐȾÄͼ×ÑõÎ÷ÁÖ½ð»ÆÉ«ÆÏÌÑÇò¾úµÄ»¼ÕßȺÌåÖÎÁƽá¹ûµÄÓ°Ï죺һÏî»ùÓÚÒ½Ôº±³¾°µÄ»Ø¹ËÐÔÑо¿¡£
2.Ä¿µÄ£º½Ï¸ßµÄÍò¹ÅÃ¹ËØÅ¨¶ÈÖµ(¡Ý1.5 mg / L£¬Í¨¹ýŨ¶ÈÌݶȷ¨ÊÔÑé)¿ÉÄܵ¼Ö¸ÐÈ¾ÖØÖ¢Äͼ×ÑõÎ÷ÁֵĽð»ÆÉ«ÆÏÌÑÇò¾ú£¨MRSA£©µÄ»¼ÕßȺµÄÖÎÁÆÊ§°Ü¡£
3.¶ÔÌæ¿¼À­ÄþŨ¶ÈÌݶȷ¨²âµÃµÄ×îСÒÖ¾úŨ¶ÈºÍ¶ÔMRSAµÄÖÎÁƽá¹û½øÐÐÆÀ¹À£¬ÒÔÈ·¶¨Ì濼À­Äþ×îСÒÖ¾úŨ¶ÈÓ°ÏìÖÎÁƽá¹ûµÄ¶Ïµã¡£
4.½ÏµÍµÄÌæ¿¼À­Äþ×îСÒÖ¾úŨ¶ÈÄܵõ½Ò»¸öÓÐÀûµÄ½á¹û[ʵÑé×é37 (66.1%) £¬¶ÔÕÕ×é13 (28.9%); P,0.001] £¬ºÍ¸üµÍµÄѪҺ¸ÐȾÖÂËÀÂÊ[ʵÑé×é15 (26.8%) £¬¶ÔÕÕ×é22 (48.9%); P¡¡.022]¡£
5.½Ï¸ßµÄÌæ¿¼À­Äþ×îСŨ¶ÈÖµ(.1.5 mg/L)¿ÉÄÜÔ¤ÆÚµÃµ½Ò»¸ö²»ÀûµÄ½á¹û£¬²¢µ¼Ö½ÓÊÜÁËÌæ¿¼À­ÄþÖÎÁƵÄMRSA¾úѪ֢»¼Õ߸ü¸ßµÄÖÂËÀÂÊ¡£
2Â¥2013-05-28 19:20:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ wxh7420238 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 324Çóµ÷¼Á +3 k¿ÉÀÖ 2026-04-05 4/200 2026-04-06 09:54 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 0703»¯Ñ§ +15 ÄÝÄÝninicgb 2026-04-04 16/800 2026-04-06 09:28 by ѧԱtURuqU
[¿¼ÑÐ] Ò»Ö¾Ô¸C9µÄ»¯Ñ§¹¤³Ì£¨085602£© 340·Ö£¬¸Ð¾õУÄÚµ÷¼ÁÎÞÍû£¬Çóµ÷¼Á +12 ÍòÊÂÒËÕé 2026-04-04 12/600 2026-04-06 07:46 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] »¯Ñ§µ÷¼Á +17 °¬Ö¾ºã 2026-04-03 18/900 2026-04-06 07:10 by jj987
[¿¼ÑÐ] ¿¼Ñе÷¼Á +5 ÃÀÀöµÄyouth_ 2026-04-04 6/300 2026-04-06 06:57 by houyaoxu
[¿¼ÑÐ] 302·Ö 085601Çóµ÷¼ÁÍÆ¼ö +11 zyxÉϰ¶£¡ 2026-04-05 11/550 2026-04-05 22:13 by dongzh2009
[¿¼ÑÐ] ÉúÎïÓëÒ½Ò©µ÷¼Á +4 Ê®Æßsa 2026-04-05 4/200 2026-04-05 20:05 by lys0704
[¿¼ÑÐ] 266·Ö£¬Ò»Ö¾Ô¸µçÆø¹¤³Ì£¬±¾¿Æ²ÄÁÏ£¬Çó²ÄÁÏרҵµ÷¼Á +8 ÍÛºôºßºôºß 2026-04-02 9/450 2026-04-05 17:14 by lbsjt
[¿¼ÑÐ] 358Çóµ÷¼Á +7 Çïgk 2026-04-04 7/350 2026-04-05 13:29 by huangmoli
[¿¼ÑÐ] ¿¼Ñе÷¼Á +3 mcbbc 2026-04-04 3/150 2026-04-05 10:03 by barlinike
[¿¼ÑÐ] ÄÐÉú£¬Ò»Ö¾Ô¸»¦9ÉúÎïѧ071000£¬³õÊÔ308Çóµ÷¼Á +3 Áõīī 2026-04-04 3/150 2026-04-05 08:26 by barlinike
[¿¼ÑÐ] 268Çóµ÷¼Á +8 ÄãºÃtg 2026-04-03 9/450 2026-04-04 05:08 by gswylq
[¿¼ÑÐ] 350Ò»Ö¾Ô¸±±¾©º½¿Õº½Ìì´óѧ08500²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á +5 kjnasfss 2026-04-03 5/250 2026-04-03 22:29 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 338Çóµ÷¼Á +7 êɹ¦? 2026-04-03 7/350 2026-04-03 16:46 by wxiongid
[¿¼ÑÐ] ר˶ 351 086100 Ò²ÊÇ¿¼µÄ²Ä¿Æ»ù ±¾¿ÆÒ²ÊDzÄÁÏ +8 202451007219 2026-04-02 8/400 2026-04-03 09:50 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +6 ÏàÐűػá¹ââÍòÕ 2026-03-31 7/350 2026-04-02 23:16 by JourneyLucky
[¿¼ÑÐ] 379Çóµ÷¼Á +3 ?¿à¹Ï²»¿à 2026-04-01 3/150 2026-04-01 20:09 by ÄºÔÆÇ庮
[¿¼ÑÐ] 358Çóµ÷¼Á +3 ÍõÏòÑô»¨ 2026-03-31 3/150 2026-04-01 09:56 by zzchen2000
[¿¼ÑÐ] ¹þ¶û±õ¹¤Òµ´óѧ²ÄÁÏÓ뻯¹¤×¨Ë¶378Çóµ÷¼Á +3 Ëþ±ÈÎÚ˹ 2026-03-30 3/150 2026-03-30 22:55 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 297 µØÀíѧ070500 ¸´ÊÔÇóµ÷¼Á +3 СԲȦȦooo 2026-03-30 3/150 2026-03-30 21:05 by ÓàÕðyz
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û